Daniel Hernández-Baltazar

The 6-hydroxydopamine model and parkinsonian pathophysiology: Novel findings in an older model

Daniel Hernández-Baltazar, Laura Mireya Zavala-Flores, Arnulfo Villanueva-Olivo · Neurología (English Edition) · 2017 · 128 citations · Full text

Life Sciences, Neurobiology, Neuroscience +17

Activation of GSK-3β and Caspase-3 Occurs in Nigral Dopamine Neurons during the Development of Apoptosis Activated by a Striatal Injection of 6-Hydroxydopamine

Daniel Hernández-Baltazar, María Eugenia Mendoza‐Garrido, Daniel Martínez‐Fong · PLoS ONE · 2013 · 94 citations · Full text

Life Sciences, Neurobiology, Neuroscience +17

Safety of the intravenous administration of neurotensin-polyplex nanoparticles in BALB/c mice

Marı́a Eugenia Hernández, Jesus D. Rembao, Daniel Hernández-Baltazar et al. · Nanomedicine Nanotechnology Biology and Medicine · 2013 · 28 citations

Pharmacy, Pharmacokinetics, Pharmacology +15

Suicide HSVtk Gene Delivery by Neurotensin-Polyplex Nanoparticles via the Bloodstream and GCV Treatment Specifically Inhibit the Growth of Human MDA-MB-231 Triple Negative Breast Cancer Tumors Xenografted in Athymic Mice

Rosa Angélica Castillo‐Rodríguez, Martha L. Arango-Rodríguez, Lourdes Escobedo et al. · PLoS ONE · 2014 · 27 citations · Full text

Pharmacy, Molecular Pharmaceutics, Oncology +17

Optimizing NTS-Polyplex as a Tool for Gene Transfer to Cultured Dopamine Neurons

Daniel Hernández-Baltazar, Daniel Martínez‐Fong, Louis‐Éric Trudeau · PLoS ONE · 2012 · 19 citations · Full text

Life Sciences, Biotechnology, Neuroscience +17